StockData

Exicure, Inc. (XCUR) stock

XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 20, 2026Score 4/30
$0.98−0.06 (-5.77%)

Close on Nov 19, 2026Market cap $6.42MP/E –Yield –

Exicure revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Exicure's revenue for the twelve months ending Sep 30, 2026 was $0. For fiscal 2025 it was $0, down 100.0% from the year before. The highest annual figure on record is $28.83M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0-100.0%
FY2024Dec 31, 2024$500.00K–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$28.83M–
FY2021Dec 31, 2021-$483.00K-102.9%
FY2020Dec 31, 2020$16.61M+1181.9%
FY2019Dec 31, 2019$1.30M+998.3%
FY2018Dec 31, 2018$118.00K-98.8%
FY2017Dec 31, 2017$9.72M+838.1%
FY2016Dec 31, 2016$1.04M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$0–
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$0–
Q4 FY2025Dec 31, 2025$0–
Q3 FY2025Sep 30, 2025$0–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2024Dec 31, 2024$0–
Q3 FY2024Sep 30, 2024$0–
Q2 FY2024Jun 30, 2024$0–
Q1 FY2024Mar 31, 2024$500.00K–
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$0-100.0%
Q2 FY2023Jun 30, 2023$0-100.0%
Q1 FY2023Mar 31, 2023$0-100.0%
Q4 FY2022Dec 31, 2022$21.77M+928.0%
Q3 FY2022Sep 30, 2022$2.02M–
Q2 FY2022Jun 30, 2022$2.47M+3027.8%
Q1 FY2022Mar 31, 2022$2.57M+157.3%
Q4 FY2021Dec 31, 2021$2.12M+1412.9%
Q3 FY2021Sep 30, 2021-$3.68M-250.5%
Q2 FY2021Jun 30, 2021$79.00K-98.4%
Q1 FY2021Mar 31, 2021$997.00K-89.1%
Q4 FY2020Dec 31, 2020$140.00K-54.8%
Q3 FY2020Sep 30, 2020$2.44M+363.6%
Q2 FY2020Jun 30, 2020$4.85M+1016.8%
Q1 FY2020Mar 31, 2020$9.18M+36632.0%
Q4 FY2019Dec 31, 2019$310.00K+5066.7%
Q3 FY2019Sep 30, 2019$527.00K+824.6%
Q2 FY2019Jun 30, 2019$434.00K+2184.2%
Q1 FY2019Mar 31, 2019$25.00K-30.6%
Q4 FY2018Dec 31, 2018$6.00K-99.7%
Q3 FY2018Sep 30, 2018$57.00K-91.7%
Q2 FY2018Jun 30, 2018$19.00K–
Q1 FY2018Mar 31, 2018$36.00K–
Q4 FY2017Dec 31, 2017$2.10M–
Q4 FY2016Dec 31, 2016$690.00K–

More Exicure figures

See a number that looks wrong?